Emerging Infectious Diseases (Jul 2004)

Recombinant Viruses and Early Global HIV-1 Epidemic

  • Marcia L. Kalish,
  • Kenneth E. Robbins,
  • Danuta Pieniazek,
  • Amanda Schaefer,
  • Nzila Nzilambi,
  • Thomas C. Quinn,
  • Michael E. St. Louis,
  • Ae S. Youngpairoj,
  • Jonathan Phillips,
  • Harold W. Jaffe,
  • Thomas M. Folks

DOI
https://doi.org/10.3201/eid1007.030904
Journal volume & issue
Vol. 10, no. 7
pp. 1227 – 1234

Abstract

Read online

Central Africa was the epicenter of the HIV type 1 (HIV-1) pandemic. Understanding the early epidemic in the Democratic Republic of the Congo, formerly Zaire, could provide insight into how HIV evolved and assist vaccine design and intervention efforts. Using enzyme immunosorbent assay, we tested 3,988 serum samples collected in Kinshasa in the mid-1980s and confirmed seroreactivity by Western blot. Polymerase chain reaction of gag p17, env C2V3C3, and/or gp41; DNA sequencing; and genetic analyses were performed. Gene regions representing all the HIV-1 group M clades and unclassifiable sequences were found. From two or three short gene regions, 37% of the strains represented recombinant viruses, multiple infections, or both, which suggests that if whole genome sequences were available, most of these strains would have mosaic genomes. We propose that the HIV epidemic was established in Central Africa by the early 1980s and that some recombinant viruses most likely seeded the early global epidemic.

Keywords